Year To Quarter End Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7362167

Concept 2023-03-01 to
2023-11-30
2022-03-01 to
2022-11-30
Year to quarter end statement of income
Statement of income
Net sales
102,827,000,000 JPY
91,881,000,000 JPY
Cost of sales
44,227,000,000 JPY
39,100,000,000 JPY
Gross profit (loss)
58,600,000,000 JPY
52,781,000,000 JPY
Selling, general and administrative expenses
46,330,000,000 JPY
44,274,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
12,270,000,000 JPY
8,506,000,000 JPY
Non-operating income
Interest income
1,806,000,000 JPY
398,000,000 JPY
Dividend income
705,000,000 JPY
626,000,000 JPY
Non-operating income
4,472,000,000 JPY
4,687,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
12,000,000 JPY
Non-operating expenses
80,000,000 JPY
189,000,000 JPY
Ordinary profit (loss)
16,661,000,000 JPY
13,003,000,000 JPY
Extraordinary income
Extraordinary income
1,000,000 JPY
142,000,000 JPY
Extraordinary losses
Extraordinary losses
3,000,000 JPY
116,000,000 JPY
Profit (loss) before income taxes
16,659,000,000 JPY
13,029,000,000 JPY
Income taxes
4,179,000,000 JPY
3,208,000,000 JPY
Profit (loss)
12,480,000,000 JPY
9,821,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.